Immunotherapy combo shows promise for tough lung cancers

NCT ID NCT06810609

First seen Jan 11, 2026 · Last updated May 06, 2026 · Updated 15 times

Summary

This study tests whether adding immunotherapy before and after standard treatments (surgery or chemoradiation) can help people with stage III non-small cell lung cancer live longer without the cancer coming back. About 176 adults with resectable or borderline resectable tumors will be randomly assigned to receive the new combination or standard care. The main goal is to see if the new approach improves two-year event-free survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER NON-SMALL CELL CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johannes Wesling Klinikum Minden Mühlenkreiskliniken, Hämatologie und Onkologie

    RECRUITING

    Minden, North Rhine-Westphalia, 32429, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Klinikum Stuttgart

    RECRUITING

    Stuttgart, Baden-Wurttemberg, 70174, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Bonn

    RECRUITING

    Bonn, 53127, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Freiburg

    RECRUITING

    Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Gießen

    NOT_YET_RECRUITING

    Giessen, Hesse, 35392, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.